Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-22
2005-03-22
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S256000, C514S293000, C544S126000, C544S333000, C546S082000, C546S083000
Reexamination Certificate
active
06869949
ABSTRACT:
The invention relates to imidazopyridines of a certain formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion-inhibiting properties.
REFERENCES:
patent: 4468400 (1984-08-01), Gold et al.
patent: 6160119 (2000-12-01), Senn-Bilfinger
patent: 6197783 (2001-03-01), Senn-Bilfinger et al.
patent: 6384048 (2002-05-01), Senn-Bilfinger
patent: 6436953 (2002-08-01), Senn-Bilfinger
patent: 6503923 (2003-01-01), Senn-Bilfinger
patent: WO 9527714 (1995-10-01), None
patent: WO 9842707 (1998-10-01), None
patent: WO 9854188 (1998-12-01), None
patent: WO 0017200 (2000-03-01), None
patent: WO 0026217 (2000-05-01), None
patent: WO 0063211 (2000-10-01), None
patent: WO 0172754 (2001-10-01), None
patent: WO 0172755 (2001-10-01), None
patent: WO 0172756 (2001-10-01), None
patent: WO 0172757 (2001-10-01), None
Senn-Bilfinger, J., et al., “Preparation of imidazonaphthyridines for prevention and treatment of gastrointestinal disease”. Chemical Abstracts, vol. 132, No. 11, Abstract No. 137385, 2000.
Kaminksi, James J., et al., “Antiulcer Agents. 4. Conformational Considerations and the Antiulcer Activity of Substituted Imidazo{[1,2-a ] pyridines and Related Analogues”. J. Med. Chem.: 32, 1686-1700, 1989.
Kaminski, James J., et al., “Antiulcer Agents. 5. Inhibition of Gastric H+/K+-ATPase by Substituted Imidazo[1,2-a] pyridines and Related Analogues and Its Implication in Modeling the High Affinity Potassium Ion Binding Site of the Gastric Proton Pump Enzyme”. J. Med. Chem.: 34, 533-541, 1991.
Kaminski, James J., et al., “Antiulcer Agents. 6. Analysis of the in Vitro Biochemical and in Vivo Gastric Antisecretory Activity of Substituted Imidazo{[1,2-a ] pyridines and Related Analogues Using Comparative Molecular Field Analysis and Hypothetical Active Lattice Methodologies”. J. Med. Chem.: 40, 427-436, 1997.
Buhr Wilm
Kohl Bernhard
Senn-Bilfinger Jörg
Zimmermann Peter
Altana Pharma AG
Juneau Todd L.
McGee Sheldon M.
Nath & Associates PLLC
Powers Fiona T.
LandOfFree
Polysubstituted imidazopyridines as gastric secretion... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polysubstituted imidazopyridines as gastric secretion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polysubstituted imidazopyridines as gastric secretion... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3416628